Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2025-07-22–present
Board Member
Bausch Health Companies Inc. (BHC)Equibles does not estimate personal net worth.
Get an email with a short summary when Bausch Health Companies Inc. publishes a filing, an earnings call transcript or a press release.
Get BHC alertsMichael Goettler is recorded as Board Member at Bausch Health Companies Inc. (BHC) since July 22, 2025. Bausch Health Companies Inc. reported in an 8-K filed July 1, 2026 that Michael Goettler resigned as Board of Directors, effective June 30, 2026. Bausch Health Companies Inc. reported in an 8-K filed July 24, 2025 that Michael Goettler was appointed member of the Board of Directors, effective July 22, 2025. Bausch Health Companies Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Bausch Health Companies Inc. includes Joseph Papa (CEO), Thomas Appio (CEO), Thomas J. Appio (CEO and Board Member) and 7 others.
“On June 26, 2026, Mr. Michael Goettler notified Bausch Health Companies Inc. (the “Company”) of his decision to resign from the Board of Directors (the “Board”), effective June 30, 2026, in connection with his appointment as President and Chief Executive Officer of Knoa Pharma LLC.”
“the Board increased the size of the Board from ten to twelve members and appointed Michael Goettler and Sandra Leung, in each case effective as of July 22, 2025.”
2025-07-22–present
2025-07-22–2026-06-30
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2025-07-22–present